Home
About us
Corporate Profile
Awards and Qualification
Social Responsibility
Diseases and solutions
Cardiovascular diseases
Uncontrolled and Resistant Hypertension
Product Center
Bioresorbable Scaffolds (BRS)
Renal Denervation (RDN)
Investor Relations
Corporate Information
Corporate Governance
Financial Reports
Performance Report
Prospectus
Announcements and Circulars
Investor Enquiries
News Center
News
Video
Contact us
Contact Us/Recruitment
简 / 繁 / EN
简体中文
繁體中文
English
News Center
Keep up to date with our news
Major News! JACC Journal: Bioheart Bioabsorbable Scaffold 3-year Follow up Results Released
2025-01-27
Major News! Circulatio：Effectness and Safety of Iberis® Radiofrequency RDN System for the Treatment of Uncontrolled Primary Hypertension
2024-11-19
Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023
2023-06-30
上一页
1
下一页
